Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development of Non-invasive Prenatal Test for Microdeletion/Duplication and Other Genetic Syndromes Based on Fetal DNA Isolated From Maternal Blood

NCT02109770 is registered in ClinicalTrials.gov with Natera, Inc. as lead sponsor.

NCT NCT02109770
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02109770 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development of Non-invasive Prenatal Test for Microdeletion/Duplication and Other Genetic Syndromes Based on Fetal DNA Isolated From Maternal Blood
Lead sponsor
Natera, Inc.
Phase
Observational
Overall status
Completed
Start date
October 31, 2012
Completion date
August 31, 2019
Enrollment
216 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

microdeletion syndromes, sex chromosome abnormalities, trisomy 13, trisomy 18, trisomy 21